SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,453,000 | +57.4% | 11,263 | -8.0% | 0.01% | +42.9% |
| Q3 2019 | $923,000 | -71.5% | 12,237 | -42.5% | 0.01% | -72.0% |
| Q2 2019 | $3,235,000 | +27.9% | 21,293 | +0.3% | 0.02% | +19.0% |
| Q1 2019 | $2,530,000 | +12.9% | 21,235 | +3.4% | 0.02% | -4.5% |
| Q4 2018 | $2,241,000 | -47.8% | 20,537 | -22.8% | 0.02% | -48.8% |
| Q3 2018 | $4,296,000 | +77.6% | 26,595 | +45.4% | 0.04% | +30.3% |
| Q2 2018 | $2,419,000 | +85.5% | 18,293 | +3.9% | 0.03% | +83.3% |
| Q1 2018 | $1,304,000 | +18.9% | 17,609 | -10.8% | 0.02% | +20.0% |
| Q4 2017 | $1,097,000 | +46.7% | 19,733 | +19.6% | 0.02% | +25.0% |
| Q3 2017 | $748,000 | +113.1% | 16,497 | +58.6% | 0.01% | +100.0% |
| Q2 2017 | $351,000 | +17.8% | 10,402 | +3.2% | 0.01% | 0.0% |
| Q1 2017 | $298,000 | +11.6% | 10,076 | +3.2% | 0.01% | 0.0% |
| Q4 2016 | $267,000 | -55.1% | 9,761 | +0.7% | 0.01% | -57.1% |
| Q3 2016 | $595,000 | +286.4% | 9,694 | +18.8% | 0.01% | +250.0% |
| Q2 2016 | $154,000 | – | 8,160 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
| Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
| Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
| Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
| Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
| STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
| Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
| RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
| Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |